Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity.
OBJECTIVE
Cytomegalovirus (CMV) infection or reactivation from latency in vascular cells have been shown to contribute to atherosclerosis. CMV-infected endothelial cells (ECs) exhibit enhanced adhesion and procoagulant properties, changes compatible with processes observed in atherogenesis. The major immediate early promoter drives immediate early gene transcription. Immediate early (IE) gene products, IE72 and IE84, function as transcription factors and thereby influence expression of cellular genes, in permissive cells as well as in abortive infections, in which viral activity is limited to immediate early expression. ECs have been shown to harbor latent CMV, support abortive CMV infection and, under certain conditions, are permissive to productive viral infection. The objective of this study was to determine whether immediate early expression alone (in the absence of further progression of the virus life-cycle) results in the activation of EC genes associated with atherogenesis.


METHODS
The study was conducted in an in vitro transient transfection system in human and bovine vascular ECs, with CMV immediate early gene expression vectors and plasmids containing promoter sequences of adhesion molecule, growth factor and viral promoters driving the transcription of reporter genes.


RESULTS
CMV immediate early gene expression resulted in an increase in monocyte adhesion to ECs and in the relative promoter activities of cellular growth factor and adhesion molecule genes. In addition, the viral major immediate early promoter was regulated in EC by thrombin and the immediate early gene products.


CONCLUSIONS
These results infer the possible existence of a positive feedback mechanism in the developing atherosclerotic lesion, in which enhanced immediate early gene expression leads to subsequent activation of EC genes, which might in turn result in further activation of CMV activity.
Guetta
E
E
Department of Human Genetics and Molecular Medicine, Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel. guetta@post.tau.ac.il
Scarpati
E M
EM
DiCorleto
P E
PE
D000818:Animals; D002417:Cattle; D002448:Cell Adhesion / Q000235:genetics; D018929:Cell Culture Techniques; D003587:Cytomegalovirus / Q000235:genetics / Q000378:metabolism*; D019040:E-Selectin / Q000235:genetics; D004730:Endothelium, Vascular / Q000166:cytology / Q000821:virology*; D015870:Gene Expression; D015967:Gene Expression Regulation, Viral / Q000187:drug effects; D017781:Genes, Immediate-Early; D006801:Humans; D017874:Immediate-Early Proteins / Q000378:metabolism*; D009000:Monocytes / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000235:genetics; D011401:Promoter Regions, Genetic; D013917:Thrombin / Q000494:pharmacology; D014162:Transfection; D019010:Vascular Cell Adhesion Molecule-1 / Q000235:genetics
D019040:E-Selectin; D017874:Immediate-Early Proteins; D010982:Platelet-Derived Growth Factor; D019010:Vascular Cell Adhesion Molecule-1; D013917:Thrombin